National Vaccine and Serum Institute: Recombinant SARS-CoV-2 Vaccine (CHO Cell)

Vaccine Type: Protein Subunit

This vaccine may also be referred to as Recombinant COVID-19 Vaccine (CHO cell, NVSI-06-08)

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 1 Trial

Phase 2: 1 Trial

Phase 3: 1 Trial


1 Country

Registered Trials